Germans Fault Bigger Space Budget

WEST BERLIN—West German scientists appear to be increasingly unhappy with their government’s decision to boost spending on space research at the expense of fundamental science. The Fraunhofer Society for the Promotion of Applied Research, the principal state organization funding applied sciences, has come out against the 16 percent increase for space planned in the country’s 1988 R&D budget. It echoes earlier criticism from the Max Planck Society, which is devoted to basic

Written byRichard Sietmann
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WEST BERLIN—West German scientists appear to be increasingly unhappy with their government’s decision to boost spending on space research at the expense of fundamental science.

The Fraunhofer Society for the Promotion of Applied Research, the principal state organization funding applied sciences, has come out against the 16 percent increase for space planned in the country’s 1988 R&D budget. It echoes earlier criticism from the Max Planck Society, which is devoted to basic research (See THE SCIENTIST, January 25, p. 7). The Fraunhofer Society is scheduled for a 7.5 percent increase, compared with only 2.9 percent for the Max Planck Society.

In particular, Fraunhofer officials are skeptical of the promised political and economic benefits that would stem from a greater investment in manned spaceflight. Some of the strongest criticism has come from Professor Helmar Krupp, president of one of the society’s major centers, the Karlsuhebased Fraunhofer Institute for Systems and Innovation.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies